Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R > Treatment > Co: CN. B. Brand Zanubrutinib>

---

Co: CN. B. Brand Zanubrutinib>'s subsections
(*) SA Approval Date: 2021. 11.15.
(*) USA Approval Date: 2019. 11.14.
>Received One Prior Therapy
Company
Company Pharmacy USA
Company Pharmacy USA Web-Site
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 09.14.
RTM
RTM Web-Site

Co: CN. B. Brand Zanubrutinib>'s products
This section has no products